5 Cathie Wood Novartis AG Trades
Cathie Wood started to build up the position in Novartis AG in Q4 2020 and continued to invest until Q1 2021. Since then they sold 7.22 Million shares. The investor completely sold their stake between Q2 2021 and Q4 2021.
Avg closing price
Price range
Sold -3.62 Thousand shares
Q4 2021
Avg closing price
$82.46
Price range
$78.78
-
$87.47
Sold 99.9% shares (-4.27 Million shares)
Q3 2021
Avg closing price
$88.91
Price range
$80.75
-
$95.00
Sold 40.8% shares (-2.94 Million shares)
Q2 2021
Avg closing price
$88.47
Price range
$84.00
-
$93.90
Increased shares by 238.9% (+5.09 Million shares)
Q1 2021
Avg closing price
$89.33
Price range
$82.12
-
$97.30
New holding (+2.13 Million shares)
Q4 2020
Avg closing price
$87.44
Price range
$77.45
-
$94.10
News about Novartis AG and Cathie Wood
Woodmont Investment Counsel LLC Lowers Stock Position in Novartis AG (NYSE:NVS)
Woodmont Investment Counsel LLC lowered its position in shares of Novartis AG (NYSE:NVS – Free Report) by 0.8% during the 2nd quarter, according to its most ...
Cathie Wood's Ark Invest was busy in drug stocks this week. A review of what she bought and sold:
Between Monday and Thursday, Ark Innovation bought shares of Novartis and Regeneron Therapeutics.